Swati Choudhary1, Stefan Barth2,3, Rama S Verma4. 1. Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600036, India. 2. Department of Pharmaceutical Product Development, Fraunhofer Institute for Molecular Biology and Applied Ecology IME, 52074, Aachen, Germany. stefan.barth@uct.ac.za. 3. UCT Faculty of Health Sciences, South African Research Chair in Cancer Biotechnology, Cape Town, South Africa. stefan.barth@uct.ac.za. 4. Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600036, India. vermars@iitm.ac.in.
Abstract
BACKGROUND: SNAP-tag, a self-labeling protein tag, is commonly used for in vitro and in vivo analysis of bound target proteins. We report the first evidence that SNAP-tag could be used for ex vivo detection of enriched biological markers. METHODS: Proof of concept was established for target c-kit receptor, a pathological and diagnostic marker for a variety of cancers. SNAP-tag conjugates with stem-cell factor (SCF) fusion proteins were designed and their binding and specificity was validated in vitro using flow cytometry and immunostaining. RESULTS: Ex vivo diagnostic application of the fusion protein was demonstrated in comparison with anti-c-kit antibody for peripheral blood samples from leukemia patients and colorectal tissue specimens.
BACKGROUND: SNAP-tag, a self-labeling protein tag, is commonly used for in vitro and in vivo analysis of bound target proteins. We report the first evidence that SNAP-tag could be used for ex vivo detection of enriched biological markers. METHODS: Proof of concept was established for target c-kit receptor, a pathological and diagnostic marker for a variety of cancers. SNAP-tag conjugates with stem-cell factor (SCF) fusion proteins were designed and their binding and specificity was validated in vitro using flow cytometry and immunostaining. RESULTS: Ex vivo diagnostic application of the fusion protein was demonstrated in comparison with anti-c-kit antibody for peripheral blood samples from leukemiapatients and colorectal tissue specimens.
Authors: Florian Kampmeier; Markus Ribbert; Thomas Nachreiner; Sofia Dembski; Florent Beaufils; Andreas Brecht; Stefan Barth Journal: Bioconjug Chem Date: 2009-05-20 Impact factor: 4.774
Authors: M C Béné; T Nebe; P Bettelheim; B Buldini; H Bumbea; W Kern; F Lacombe; P Lemez; I Marinov; E Matutes; M Maynadié; U Oelschlagel; A Orfao; R Schabath; M Solenthaler; G Tschurtschenthaler; A M Vladareanu; G Zini; G C Faure; A Porwit Journal: Leukemia Date: 2011-01-21 Impact factor: 11.528
Authors: Peter J Bosch; Ivan R Corrêa; Michael H Sonntag; Jenny Ibach; Luc Brunsveld; Johannes S Kanger; Vinod Subramaniam Journal: Biophys J Date: 2014-08-19 Impact factor: 4.033
Authors: Jeffrey J Day; Bernadette V Marquez; Heather E Beck; Tolulope A Aweda; Prasad D Gawande; Claude F Meares Journal: Curr Opin Chem Biol Date: 2010-10-15 Impact factor: 8.822
Authors: N Cascavilla; P Musto; G D'Arena; L Melillo; A M Carella; M P Petrilli; G Sanpaolo; M Carotenuto Journal: Haematologica Date: 1998-05 Impact factor: 9.941